Startup entity
funding accounts for 3 of the 4 tracked stories, while 1 other category carries the remainder. Of the tracked stories, 1 of 4 also mention AI, the most common co-covered peer. The 152-day window averages about 0.2 stories each week.
Last mentioned: Aug 22, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding accounts for 3 of the 4 tracked stories, while 1 other category carries the remainder. Of the tracked stories, 1 of 4 also mention AI, the most common co-covered peer. The 152-day window averages about 0.2 stories each week. The 6.8 average consequence score is above the beat benchmark of 6.7 in the same window. Each story carries 3.3 original sources on average, compared with 2.9 for the broader beat in this window. We currently track 4 Startup stories that mention PitchBook, published between February 18, 2026 and July 19, 2026.
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 1529 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering PitchBook. Shared-story counts are live from our verified record — not editorial picks.
Concentration hits record high
Experienced firms capture 91% of all VC capital raised in Q1 2026, the highest level in PitchBook's dataset.
BBG Ventures closes new fund
Nisha Dua and Susan Lyne complete a fundraise for BBG Ventures, relying on their track record and niche focus.
Market downturn begins
Tech stocks sell off, the IPO window shuts, and LPs become cautious, making fundraising extremely hard for emerging VC managers.
The $3.8 billion raised by MENA startups in 2025 was a record, yet the region’s venture ecosystem still lacks the exit opportunities that fuel sustainable growth. Without a stronger pipeline of IPOs and acquisitions, the funding boom risks becoming a bubble of unfilled potential.
The biotech venture market is splitting in two: established clinical-stage companies are raising megafunds at a blistering pace, while preclinical and seed-stage biotechs face a deepening funding winter. The contrast underscores a structural shift in startup financing strategies.
Emerging VC fund managers are getting squeezed as LPs pour record capital into established firms. Nisha Dua of BBG Ventures shares how to navigate the crunch and why niche focus still wins.
Source: Melia Russell · Business Insider
Thrive Capital has closed its record-breaking $10 billion 'Thrive X' fund, nearly doubling its previous capital raise. The vehicle is strategically positioned to back category-defining leaders in artificial intelligence and space technology, specifically targeting late-stage growth in portfolio anchors like OpenAI and SpaceX.
Source: Pensions & Investments · PitchBook
PitchBook is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
